News

FDA Approves Evkeeza for Young Children with Ultra-Rare Form of High Cholesterol

March 31, 2023

FDA has approved Evkeeza for young children with homozygous familial hypercholesterolemia.

Takeda Gets Approval in Japan for Entyvio Subcutaneous Injection

March 30, 2023

Takeda received approval in Japan for a subcutaneous injection formulation of Entyvio (vedolizumab) for treating ulcerative colitis.

Exothera Partners with Remedium to Scale-Up Manufacturing of Gene Therapy Drug Candidate

March 30, 2023

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

Takeda to Invest ¥‎100 Billion (US$754 Million) into New Plasma Therapy Manufacturing Facility

March 30, 2023

Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.

Roche Collaborates with Lilly to Enhance Early Diagnosis of Alzheimer’s Disease

March 30, 2023

Roche and Lilly will collaborate on the development of Roche Diagnostics’ Elecsys Amyloid Plasma Panel.

US Supreme Court Weighs Biologics Patents in Amgen vs. Sanofi Case

March 30, 2023

The Supreme Court heard oral arguments concerning the legitimacy of “genus clauses” in bio/pharma patents.

FDA Approves First Over-the-Counter Naloxone Nasal Spray

March 29, 2023

Narcan, from Emergent Solutions, will be the first naloxone product permitted for use without prescription by FDA.

PharmaBlock Opens New R&D Facility in Pennsylvania

March 27, 2023

PharmaBlock has opened a new R&D facility in Pennsylvania, expanding its capacity to deliver GMP projects.

Ingredion Announces Strategic Investments in India Expanding into High-Value Pharmaceutical Ingredients

March 27, 2023

Ingredion has completed two strategic investments in India with Amishi Drugs & Chemicals and Mannitab Pharma Specialties.

Moderna and Generation Bio Announce Strategic Collaboration

March 24, 2023

Moderna and Generation Bio have announced a strategic collaboration to develop non-viral genetic medicines.